Cold-Pressed Rosehip Oil vs. CO₂ Extract: ROI for EU Formulators

The Rosehip Sourcing Decision That Impacts Your Bottom Line

Rosehip seed oil has secured its place as one of the most sought-after botanical actives in premium European skincare. Rich in trans-retinoic acid precursors, essential fatty acids (EFAs), and tocopherols, it commands serious attention from R&D teams and procurement managers alike. But the sourcing decision—cold-pressed oil versus CO₂ extract—carries significant implications for formulation performance, shelf life, compliance burden, and ultimately, return on investment.

This article provides a structured comparison to help sourcing specialists and formulators make the most commercially sound decision for their specific product context.

---

Understanding the Two Extraction Methods

Cold-Pressed Rosehip Seed Oil

Cold pressing mechanically extracts oil from *Rosa canina*, *Rosa rubiginosa*, or *Rosa mosqueta* seeds at temperatures typically below 40–50°C. The result is a full-spectrum oil retaining:

• Linoleic acid (omega-6): 44–54%
• Alpha-linolenic acid (omega-3): 19–35%
• Oleic acid: 14–22%
• Tocopherols and carotenoids as natural antioxidants
• Trace retinoic acid and retinoic acid precursors

Cold-pressed oil is a familiar, INCI-codeable cosmetic ingredient (*Rosa Canina Fruit Oil*) with a well-established regulatory track record under EU Cosmetics Regulation (EC) No 1223/2009.

CO₂ Extract (Supercritical or Subcritical)

CO₂ extraction uses carbon dioxide under controlled pressure and temperature to isolate a concentrated phytochemical fraction. Supercritical CO₂ (above 31°C, 74 bar) yields a lipophilic extract rich in carotenoids, tocopherols, and fatty acids, while subcritical parameters can shift the profile toward more polar compounds.

The resulting extract is significantly more concentrated—typically used at 0.1–2% in formulations versus the 1–10% typical for cold-pressed oil—and demonstrates enhanced stability against oxidative degradation due to reduced exposure to heat and oxygen during processing.

---

Head-to-Head Comparison: Five ROI Dimensions

1. Raw Material Cost and Usage Rate

Cold-pressed rosehip seed oil is broadly available across EU-certified supplier networks, with typical B2B pricing ranging from €15–€45/kg depending on origin certification (organic, fair trade) and volume tier. It is used at relatively high percentages in formulations.

CO₂ extracts command a significant price premium—often €80–€250/kg—but the ultra-low usage rates (as little as 0.1%) mean the cost-in-use per kilogram of finished product can be comparable or lower. For high-margin prestige formulations, this trade-off frequently favours the extract.

Procurement insight: Always calculate cost-in-use, not cost-per-kilogram, when comparing these two formats.

2. Bioactivity and Performance Credentials

CO₂ extracts deliver a concentrated carotenoid and tocopherol payload, making them particularly effective in anti-ageing and brightening claims. Published data indicates CO₂ rosehip extracts can contain 3–8× higher carotenoid concentrations than cold-pressed equivalents from the same source material.

Cold-pressed oil, however, offers the complete EFA matrix that supports skin barrier repair—a clinically validated mechanism particularly relevant for sensitive skin, eczema-prone, and post-procedure formulations. The omega-3/omega-6 balance in cold-pressed rosehip is difficult to replicate via extraction alone.

R&D recommendation: Match the ingredient format to your primary efficacy claim. Barrier repair → cold-pressed. Brightening/anti-ageing → CO₂ extract, potentially in combination.

3. Formulation Stability and Shelf Life

This is where cold-pressed rosehip seed oil presents its most significant commercial risk. Its high polyunsaturated fatty acid (PUFA) content makes it inherently prone to oxidative rancidity. Without rigorous antioxidant support (tocopherol blends, rosemary CO₂ antioxidant), shelf life challenges can result in:

• Sensory off-notes within 12–18 months of production
• Regulatory complaints and product returns
• Increased quality control overhead

CO₂ extracts, processed without water and with minimal oxygen exposure, exhibit superior inherent oxidative stability, reducing QC burden and supporting 24–36 month shelf life targets more reliably.

4. Regulatory and Documentation Fit (EU Market)

Both formats are compatible with EU Cosmetics Regulation (EC) No 1223/2009, but documentation requirements differ:

• Cold-pressed oil: Straightforward INCI designation, extensive safety history, lower PIF complexity
• CO₂ extract: May require more detailed characterisation data in the Product Information File (PIF), particularly if novel concentration ratios are used; INCI designation as *Rosa Canina Seed Extract* is established but supplier-specific CoA data becomes critical

For companies operating under COSMOS or NATRUE certification, both formats are eligible, but cold-pressed oil is generally simpler to certify and audit.

5. Supply Chain Resilience and Sourcing Risk

Cold-pressed rosehip seed oil benefits from a broader, more competitive supplier base across Chile, South Africa, Central Asia, and Eastern Europe, with multiple EU-certified importers providing pricing leverage and supply security.

CO₂ extraction infrastructure is more concentrated, with fewer specialist producers. This can introduce single-source dependency risk and longer lead times, particularly for certified organic grades. Procurement teams should qualify at least two approved suppliers for business continuity.

---

Decision Framework: Which Format Wins for Your Use Case?

| Factor | Cold-Pressed Oil | CO₂ Extract |

|---|---|---|

| Budget formulations | ✅ Preferred | ❌ Higher entry cost |

| Prestige/luxury SKUs | ✅ Viable | ✅ Preferred |

| Barrier repair claims | ✅ Stronger | ⚠️ Limited EFA profile |

| Anti-ageing/brightening | ⚠️ Moderate | ✅ Stronger |

| Stability-sensitive formats | ⚠️ Requires management | ✅ Preferred |

| COSMOS certification | ✅ Simpler | ✅ Achievable |

| Anhydrous formulations | ✅ Direct use | ✅ Ideal |

---

The Hybrid Approach: A Growing Industry Strategy

Leading EU formulators are increasingly adopting a dual-ingredient strategy—combining cold-pressed rosehip seed oil (for its EFA matrix and skin-feel) with a low-level CO₂ extract (for concentrated carotenoid and antioxidant activity). This approach:

• Supports multi-claim marketing (barrier + brightening + anti-ageing)
• Optimises total active payload per formulation cost
• Provides richer CoA documentation for marketing and regulatory teams

At TANDOR, we supply both formats from verified, EU-compliant producers with full traceability documentation, batch-specific CoAs, and safety dossier support.

---

Key Takeaways for Procurement and R&D Teams

• Calculate cost-in-use, not unit price, when comparing cold-pressed versus CO₂ extract
• Align format to primary efficacy claim: EFA-driven barrier repair favours cold-pressed; concentrated bioactives favour CO₂
• Factor stability management costs into total cost of ownership for cold-pressed formats
• Qualify multiple suppliers for CO₂ extracts to protect supply chain resilience
• Consider hybrid formulation strategies to maximise both performance breadth and marketing claims

The right choice is rarely absolute—it is context-dependent. But with the right data and a reliable supply partner, the ROI calculation becomes significantly clearer.